Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT

PHASE3RecruitingINTERVENTIONAL

Enrollment

190

Participants

Timeline

Start Date

November 10, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Asymptomatic Brain MetastasesDriver Mutation Positive Non-small Cell Lung Cancer

Interventions

RADIATION

Stereotactic radiosurgery/whole brain radiotherapy

SRS/ WBRT for asymptomatic brain metastases depending on the number of brain metastases

DRUG

Tyrosine kinase inhibitor

TKI

Trial Locations (1)

RECRUITING

Tata Memorial Hospital, Mumbai

All Listed Sponsors

lead

Tata Memorial Hospital

OTHER_GOV

NCT05236946 - Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT | Biotech Hunter | Biotech Hunter